Showing 1 - 10 of 542
Persistent link: https://www.econbiz.de/10011947497
Persistent link: https://www.econbiz.de/10008456154
Persistent link: https://www.econbiz.de/10003987326
In this paper, we analyze data from the Italian National Register of Rare Diseases (NRRD) focusing, in particular, on the geo-temporal distribution of patients affected by neurofibromatosis type 1 (NF1, ICD9CM code 237.71). The aim is at deriving a corrected measure of incidence for the period...
Persistent link: https://www.econbiz.de/10010976012
This report reports on an innovative, multi-method research evaluation of the ethical capacities of advocates (mainly barristers) within three years of practising with higher rights in England and Wales. It is based on survey evidence, interviews and expert assessment of responses to ethical...
Persistent link: https://www.econbiz.de/10012981533
This article explores how an Eastern European country could deal with orphan drugs access, combining EU policies with its own national settings. The cross-sectional observational study takes the total number of orphan drugs (61) available on EU level by March 2011, and then consecutively filters...
Persistent link: https://www.econbiz.de/10011048365
Persistent link: https://www.econbiz.de/10011476372
In the last years there has been a significant increase in reported cases of pertussis in developed countries, in spite of high rates of childhood immunization. Health institutions have recommended different vaccination strategies to reduce child morbidity and mortality: vaccination of...
Persistent link: https://www.econbiz.de/10011048327
The growing movement of innovative approaches to chronic disease management in Europe has not been matched by a corresponding effort to evaluate them. This paper discusses challenges to evaluation of chronic disease management as reported by experts in six European countries.
Persistent link: https://www.econbiz.de/10011048313
Persistent link: https://www.econbiz.de/10008497313